Product
A244
2 clinical trials
1 indication
Indication
HIVClinical trial
Randomized, Double Blind Evaluation of Late Boost Strategies With IHV01 (FLSC in Aluminum Phosphate) and A244 With or Without ALFQ for HIV-uninfected Participants in the HIV Vaccine Trial RV306 / WRAIR 1920Status: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Ranging Doses of ALFQ Adjuvant in a Candidate HIV Vaccine Containing A244 and B.65321Status: Recruiting, Estimated PCD: 2023-10-23